Dziubla:Research - Revision history

Thomas Dziubla at 16:25, 9 October 2011

Thomas Dziubla — Sun, 09 Oct 2011 16:25:10 GMT

←Older revision		Revision as of 16:25, 9 October 2011
Line 4:		Line 4:
	\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|		\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|
	<div align="justify" style="padding: .4em .9em .9em">		<div align="justify" style="padding: .4em .9em .9em">
-	~~The past 15 years~~ of biomaterials ~~research have resulted in multiple active polymer concepts (e~~.~~g. polymer prodrugs, drug targeting, nanoparticles, responsive materials)~~ ~~which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent~~ materials ~~and devices which~~ can ~~be applied to specific medical applications. This narrow in scope design approach provides~~ a ~~means for translational biomaterials research while simultaneously permitting the discovery~~ of ~~unmet biomaterial needs.<p>~~	+	Our laboratory is focused on the application specific design of active biomaterials. While active materials can take a variety of forms, our work has focused on affinity based interactions and oxidative stress management as our primary approaches for eliciting this control.
-	~~This approach~~ has ~~manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers~~ and ~~post-surgical adhesion barriers.~~	+
-	~~Recently, we have been researching ways to inhibit the ability of emerging resistant bacterias and infections through the use of~~ our ~~antioxidant polymers~~.	+
	\|}		\|}

David Cochran at 16:39, 25 May 2011

David Cochran — Wed, 25 May 2011 16:39:19 GMT

←Older revision		Revision as of 16:39, 25 May 2011
Line 6:		Line 6:
	The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<p>		The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<p>
	This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers.		This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers.
		+	Recently, we have been researching ways to inhibit the ability of emerging resistant bacterias and infections through the use of our antioxidant polymers.
	\|}		\|}

Thomas Dziubla at 03:16, 4 February 2008

Thomas Dziubla — Mon, 04 Feb 2008 03:16:05 GMT

←Older revision		Revision as of 03:16, 4 February 2008
Line 3:		Line 3:
	\|- valign="top"		\|- valign="top"
	\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|		\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|
-	<div style="padding: .4em .9em .9em">	+	<div align="justify" style="padding: .4em .9em .9em">
-	The past 15 years of biomaterials research have resulted in multiple active polymer concepts(e.g., polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<br>	+	The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<p>
	This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers.		This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers.
-	~~</div>~~
	\|}		\|}

Thomas Dziubla at 03:05, 4 February 2008

Thomas Dziubla — Mon, 04 Feb 2008 03:05:19 GMT

←Older revision		Revision as of 03:05, 4 February 2008
Line 4:		Line 4:
	\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|		\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|
	<div style="padding: .4em .9em .9em">		<div style="padding: .4em .9em .9em">
-	The ~~focus~~ of ~~Dr. Dziubla’s~~ research is in ~~the tailored design of polymeric biomaterial systems~~ to ~~fulfill~~ specific medical ~~needs~~. ~~Current projects being studied is~~ the ~~development~~ of antioxidant polymer nanocarriers ~~for the treatment of vascular oxidative stress~~ and ~~affinity based polymeric barriers for the prevention of~~ post surgical ~~adhesions~~.	+	The past 15 years of biomaterials research have resulted in multiple active polymer concepts(e.g., polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<br>
-	</div>	+	This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers.
		+	</div>
	\|}		\|}

Thomas Dziubla at 01:41, 4 February 2008

Thomas Dziubla — Mon, 04 Feb 2008 01:41:30 GMT

←Older revision		Revision as of 01:41, 4 February 2008
Line 4:		Line 4:
	\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|		\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|
	<div style="padding: .4em .9em .9em">		<div style="padding: .4em .9em .9em">
-
-	~~[[Image:dziubla-placehold.jpg\|thumb\|right\|]]~~
	The focus of Dr. Dziubla’s research is in the tailored design of polymeric biomaterial systems to fulfill specific medical needs. Current projects being studied is the development of antioxidant polymer nanocarriers for the treatment of vascular oxidative stress and affinity based polymeric barriers for the prevention of post surgical adhesions.		The focus of Dr. Dziubla’s research is in the tailored design of polymeric biomaterial systems to fulfill specific medical needs. Current projects being studied is the development of antioxidant polymer nanocarriers for the treatment of vascular oxidative stress and affinity based polymeric barriers for the prevention of post surgical adhesions.
-
	</div>		</div>
	\|}		\|}

Thomas Dziubla at 01:38, 4 February 2008

Thomas Dziubla — Mon, 04 Feb 2008 01:38:40 GMT

←Older revision		Revision as of 01:38, 4 February 2008
Line 1:		Line 1:
	{{Template:Dziubla}}		{{Template:Dziubla}}
		+	{\|
		+	\|- valign="top"
		+	\|width=808px class="MainPageBG" style="border: 2px solid #000000; color: #000000; background-color: #FFFFFF"\|
		+	<div style="padding: .4em .9em .9em">

		+	[[Image:dziubla-placehold.jpg\|thumb\|right\|]]
	The focus of Dr. Dziubla’s research is in the tailored design of polymeric biomaterial systems to fulfill specific medical needs. Current projects being studied is the development of antioxidant polymer nanocarriers for the treatment of vascular oxidative stress and affinity based polymeric barriers for the prevention of post surgical adhesions.		The focus of Dr. Dziubla’s research is in the tailored design of polymeric biomaterial systems to fulfill specific medical needs. Current projects being studied is the development of antioxidant polymer nanocarriers for the treatment of vascular oxidative stress and affinity based polymeric barriers for the prevention of post surgical adhesions.
		+
		+	</div>
		+	\|}

Thomas Dziubla at 01:37, 4 February 2008

Thomas Dziubla — Mon, 04 Feb 2008 01:37:41 GMT

←Older revision		Revision as of 01:37, 4 February 2008
Line 1:		Line 1:
	{{Template:Dziubla}}		{{Template:Dziubla}}
		+
		+	The focus of Dr. Dziubla’s research is in the tailored design of polymeric biomaterial systems to fulfill specific medical needs. Current projects being studied is the development of antioxidant polymer nanocarriers for the treatment of vascular oxidative stress and affinity based polymeric barriers for the prevention of post surgical adhesions.

Thomas Dziubla: New page: {{Template:Dziubla}}

Thomas Dziubla — Thu, 31 Jan 2008 03:45:11 GMT

New page: {{Template:Dziubla}}

New page